| 1989 |
A 73-kDa member of the Hsp70 family (Hsc70/HSPA8) binds peptide regions that target intracellular proteins for lysosomal degradation in response to serum withdrawal, and in the presence of ATP and MgCl2 enhances protein degradation in cell-free lysosomal proteolysis assays, establishing its role in chaperone-mediated autophagy (CMA). |
In vitro binding assay, cell-free lysosomal proteolysis assay, peptide sequencing, monoclonal antibody cross-reactivity |
Science |
High |
2799391
|
| 1995 |
The cochaperone Hip (Hsc70-interacting protein) binds the ATPase domains of Hsc70, dependent on prior ADP state established by Hsp40-stimulated ATP hydrolysis; Hip stabilizes the ADP-bound, high-substrate-affinity state of Hsc70, regulating its substrate binding cycle independently of a GrpE-like nucleotide exchange factor. |
Biochemical binding assays, ATPase activity measurements, reconstituted chaperone system |
Cell |
High |
7585962
|
| 1999 |
CHIP (carboxyl terminus of Hsc70-interacting protein) directly binds the C-terminal residues 540–650 of Hsc70 via its tetratricopeptide repeat domain, inhibits Hsp40-stimulated ATPase activity of Hsc70/Hsp70, reduces luciferase refolding and substrate binding, and thereby negatively regulates the Hsc70 chaperone cycle. |
Yeast two-hybrid, GST pulldown, in vitro ATPase assay, luciferase refolding assay, co-immunoprecipitation from human skeletal muscle |
Molecular and cellular biology |
High |
10330192
|
| 2001 |
CHIP functions with Hsc70 to sense the folded state of CFTR; CHIP's U-box promotes ubiquitination of aberrant/immature CFTR and targets it for proteasomal degradation, converting Hsc70 from a folding chaperone into a degradation factor in ER quality control. |
Overexpression/dominant-negative CHIP constructs, ubiquitination assays, co-immunoprecipitation, proteasome inhibitor experiments |
Nature cell biology |
High |
11146634
|
| 2003 |
The CHIP–Hsc70 complex ubiquitinates phosphorylated tau (but not non-phosphorylated tau) using E2 enzyme UbcH5B; phosphorylation of tau by GSK3β or Cdk5 is a recognition requirement for Hsc70 binding and subsequent CHIP-mediated ubiquitination; CHIP overexpression rescues phospho-tau-induced cell death. |
In vitro ubiquitination assay, co-immunoprecipitation, mass spectrometry, cell viability assay |
The Journal of biological chemistry |
High |
14612456
|
| 2000 |
Hsc70 associates with DeltaF508-CFTR in cystic fibrosis epithelial cells (co-immunoprecipitation); 4-phenylbutyrate (4PBA) reduces Hsc70 protein and mRNA expression and decreases Hsc70–CFTR complexes, allowing more mutant CFTR to escape degradation, identifying Hsc70 association as a determinant of ΔF508-CFTR trafficking fate. |
Co-immunoprecipitation, Western blot, Northern blot, dose-response treatment |
American journal of physiology. Cell physiology |
Medium |
10666020
|
| 2000 |
DnaJ cochaperones dj2 and dj3 (but not dj1) are the primary partner DnaJs of Hsc70 in mammalian cells; simultaneous depletion of dj2 and dj3 from reticulocyte lysate markedly reduces mitochondrial protein import and luciferase refolding, which are restored by re-addition of either; BAG-1 further stimulates ATPase activity and refolding by Hsc70-dj2 and Hsc70-dj3 pairs. |
Depletion/reconstitution of reticulocyte lysate, in vitro protein import assay, luciferase refolding assay, ATPase assay, immunocytochemistry |
The Journal of biological chemistry |
High |
10816573
|
| 2004 |
Gentamicin specifically associates with the peptide-binding domain (C-terminal one-third) of HSP73/Hsc70, induces a conformational change as detected by CD spectroscopy, and suppresses Hsc70 chaperone activity (prevention of rhodanese aggregation) in vitro; in vivo, Hsc70 and gentamicin co-localize in enlarged lysosomes of rat kidney after gentamicin-induced injury. |
Affinity chromatography (GM-affinity column), CD spectroscopy, in vitro anti-aggregation assay, limited proteolysis, immunohistochemistry |
The Journal of biological chemistry |
High |
14966137
|
| 2004 |
Hsp105α suppresses Hsc70 chaperone activity by directly binding Hsc70 and inhibiting its ATPase activity; interaction requires specific domains of Hsp105α, and inhibition of Hsc70 ATPase is concurrent with appearance of Hsp105α ATPase activity, indicating Hsp105α is a negative regulator of the Hsc70 substrate-binding cycle. |
Deletion mutant mapping, ATPase activity assay, in vitro chaperone activity assay |
The Journal of biological chemistry |
High |
15292236
|
| 2007 |
Hsc70 and auxilin/GAK are required for ATP-dependent uncoating of clathrin-coated vesicles in vivo; J-domain proteins stimulate Hsc70 binding to clathrin-coated vesicles; Hsc70 and auxilin also chaperone clathrin and adaptor proteins after dissociation to prevent aggregation and facilitate rebinding to the plasma membrane for new coated-pit formation. |
Gene knockout in cells and organisms, in vitro uncoating assay, functional endocytosis assays |
Traffic (Copenhagen, Denmark) |
High |
17488288
|
| 2007 |
BAG-1 associates with the Hsc70–Tau complex in an Hsc70-dependent manner; BAG-1 overexpression inhibits 20S proteasome-mediated degradation of tau without affecting tau ubiquitination, leading to tau accumulation; BAG-1 knockdown decreases total tau and promotes its hyperphosphorylation, demonstrating that BAG-1 regulates Hsc70-directed tau proteostasis. |
Co-immunoprecipitation, overexpression/siRNA knockdown, 20S proteasome degradation assay, phosphorylation analysis |
The Journal of biological chemistry |
Medium |
17954934
|
| 2007 |
Hsc70 co-immunoprecipitates with and is overexpressed relative to ASIC2 in high-grade glioma cells; Hsc70 siRNA knockdown reduces the constitutively activated amiloride-sensitive current, decreases cell migration, and increases ASIC2 surface expression, indicating Hsc70 promotes ASIC2 retention in the ER and thereby sustains the glioma-specific channel phenotype. |
Co-immunoprecipitation, siRNA knockdown, electrophysiology (patch clamp), migration assay, surface expression analysis |
The Journal of biological chemistry |
Medium |
17878160
|
| 2008 |
The crystal/EM structure of the Hsp110–Hsc70 nucleotide exchange complex reveals that Hsp110 acts as a nucleotide exchange factor (NEF) for Hsc70 through extensive protein–protein interactions and symmetric bridging between the nucleotides in each partner's NBD; an electropositive pore allows nucleotide entry/exit and the open-closed NBD isomerization drives nucleotide exchange. |
X-ray crystallography, electron microscopy, analytical ultracentrifugation, nucleotide exchange assays |
Molecular cell |
High |
18550409
|
| 2008 |
Simultaneous silencing of both Hsc70 and HSP72 (but not either alone) induces proteasome-dependent degradation of HSP90 client proteins, G1 cell-cycle arrest, and extensive tumor-specific apoptosis in cancer cells, while sparing non-tumorigenic cells, demonstrating functional redundancy between isoforms for HSP90 co-chaperone activity. |
siRNA knockdown (single and dual), Western blot for HSP90 clients, cell cycle analysis, apoptosis assay |
Cancer cell |
High |
18772114
|
| 2009 |
Cytosolic chaperones Hsc70 and Hsp90 complex with mitochondrial carrier precursors in the cytosol and interact with the Tom70 import receptor to promote mitochondrial import; deletion of the PiC presequence reduces Hsc70 binding and Hsc70-dependent import without affecting Hsp90, and the PiC presequence confers Hsc70 binding to heterologous fusion proteins. |
In vitro import assay, co-immunoprecipitation, GST-fusion binding assay, deletion constructs |
The Biochemical journal |
High |
19143589
|
| 2010 |
BAG3 promotes association between Hsc70 and the actin capping protein CapZβ1, facilitating CapZβ1 localization to proper sarcomeric sites; BAG3 knockdown in cardiomyocytes causes rapid myofibril disruption under mechanical stretch, CapZ ubiquitin-proteasome-mediated degradation, and loss of contractile activity, establishing a BAG3/Hsc70/CapZβ1 axis in mechanical stress resistance. |
shRNA knockdown, mechanical stretch assay, co-immunoprecipitation, ubiquitination assay, contractility assay, bag3−/− mouse model |
Circulation research |
High |
20884878
|
| 2010 |
Multiple Hsc70 molecules and a DjA1 dimer bind independently to an unfolded substrate protein; association rates and binding sites differ between Hsc70 and DjA1; Hsc70 binding induces a conformational change in its substrate-binding domain (increased trypsin resistance), and DjA1 binds bivalently to distinct peptide sequences from Hsc70, arguing against a simple DnaJ-to-Hsp70 substrate transfer model. |
Surface plasmon resonance, gel filtration, crosslinking, tryptic protection assay, peptide array binding |
The Journal of biological chemistry |
High |
20363747
|
| 2011 |
Hsc70 sequesters soluble α-synuclein in an assembly-incompetent complex in the absence of ATP; ATP addition alone or with co-chaperones Hdj1/Hdj2 reduces Hsc70's affinity for soluble α-Syn and abolishes aggregation inhibition; Hsc70 binds α-Syn fibrils with ~5-fold higher affinity than soluble α-Syn, and fibril-coated Hsc70 shows reduced cellular toxicity. |
In vitro aggregation assay, affinity measurement (fluorescence), co-chaperone modulation, toxicity assay |
The Journal of biological chemistry |
High |
21832061
|
| 2011 |
Hsc70 binding cycle controls dual outcomes for CFTR: during co-translational folding Hsc70 has a modest pro-folding role, but posttranslational Hsc70 binding is dominant and essential for CFTR ubiquitination, dislocation from the ER, and proteasomal degradation; accelerating ADP-ATP exchange (CBag) blocks ubiquitination, showing that the duration of Hsc70 binding determines CFTR fate. |
Cell-free reconstituted translation/degradation system, CBag (BAG-1 C-terminal domain) as ADP-ATP exchange accelerator, ubiquitination assay, proteasome inhibition |
Molecular biology of the cell |
High |
21697503
|
| 2014 |
Hsc70 physically interacts with Rab1A in a chaperone-dependent manner; Hsc70 knockdown decreases Rab1A protein levels and increases its ubiquitination under stress, showing Hsc70 prevents ubiquitin-proteasome-mediated degradation of stress-denatured Rab1A to support cancer cell autophagy and survival. |
Affinity purification–mass spectrometry, co-immunoprecipitation, siRNA knockdown, ubiquitination assay, autophagosome formation assay |
PloS one |
Medium |
24801886
|
| 2014 |
Hsc70 binds the 17-residue N-terminal flank of huntingtin exon 1 (HttEx1) via its substrate-binding cleft (NMR mapping to residue level); this interaction competes with homotypic N-terminal flank interactions that nucleate polyQ aggregation; Hsc70 together with Hsp40 co-chaperones inhibits HttEx1 aggregation in a polyQ-length-independent manner and modifies fibril seeding properties. |
NMR spectroscopy (surface interface mapping), in vitro aggregation assay, peptide competition |
The Journal of biological chemistry |
High |
25505179
|
| 2015 |
The J-domain of GAK is required for Hsc70-dependent clathrin uncoating; a 62-kDa fragment comprising only GAK's clathrin-binding and J-domains rescues clathrin trafficking defects in GAK-knockout fibroblasts and lethality from brain-specific GAK/auxilin double knockout, demonstrating the PTEN-like domain is dispensable for Hsc70-mediated clathrin chaperoning. |
Conditional knockout mice, domain-deletion rescue transgene, clathrin trafficking assay, behavioral analysis |
Journal of cell science |
High |
26345367
|
| 2015 |
Drosophila Hsc70-4 (ortholog of HSPA8) oligomerizes to deform membranes and promotes endosomal microautophagy (eMI) and turnover of specific synaptic proteins; its cochaperone Sgt can switch Hsc70-4 from eMI mode to chaperone-refolding mode; loss of eMI slows neurotransmission while gain of eMI increases it. |
In vitro liposome membrane-deformation screen, Drosophila genetics (loss- and gain-of-function), electrophysiology, imaging |
Neuron |
High |
26590345
|
| 2015 |
HSC70 is identified as a chaperone client handler for cardiac MYBPC3; HSC70 is the most abundant chaperone co-immunoprecipitated with both WT and mutant MYBPC3; HSC70 knockdown slows degradation of both forms while pharmacologic HSC70/Hsp70 activation accelerates it, placing HSC70 as the primary regulator of MYBPC3 protein turnover. |
Unbiased co-IP/mass spectrometry, siRNA knockdown, pharmacologic activation, pulse-chase degradation assay in primary cardiomyocytes |
JCI insight |
High |
29875314
|
| 2015 |
HSC70 interacts with the cytoplasmic tail of LAMP2A directly (photo-crosslinking in cells) and the lumenal two-domain architecture of LAMP2A supports this interaction; truncation of the membrane-distal lumenal domain reduces Hsc70 co-immunoprecipitation with LAMP2A, revealing that LAMP2A structure regulates Hsc70 docking at the lysosomal surface for CMA. |
Site-specific photo-crosslinking in cells, co-immunoprecipitation, domain truncation |
Experimental cell research |
High |
34942188
|
| 2016 |
Hsc70 physically and functionally interacts with tyrosine hydroxylase (TH); in vitro binding assays show TH binds the substrate-binding and C-terminal domains of Hsc70 directly; purified Hsc70 increases TH enzyme activity in dopaminergic cells and synaptic vesicles; Hsc70 overexpression raises TH activity and dopamine levels while Hsc70 knockdown reduces them and decreases TH association with synaptic vesicles. |
Co-immunoprecipitation from brain/cells, in vitro domain-binding assay, TH enzyme activity assay, shRNA knockdown, dopamine HPLC measurement |
The Journal of biological chemistry |
High |
27365397
|
| 2016 |
Hsc70 directly interacts with phosphatidylserine (PS) at the endosomal limiting membrane through a specific interface mapped to the C-terminus of its LID domain involving 4–5 lysine residues (KD ~4.7 µM); this PS interaction is required for cytosolic cargo internalization into endosomes during endosomal microautophagy. |
Surface plasmon resonance, NMR spectroscopy, site-directed mutagenesis, endosomal binding experiment, eMI assay |
The Journal of biological chemistry |
High |
27405763
|
| 2016 |
Connexin 43 (Cx43) competes with CDK inhibitor p27 for binding to Hsc70; Cx43 overexpression decreases Hsc70 in the cyclin D1–CDK4–p27 complex, preventing nuclear translocation of the complex and blocking G1/S transition; co-overexpression of Hsc70 restores p27 nuclear accumulation and G1/S progression. |
Co-immunoprecipitation, overexpression, cell cycle analysis (FACS), nuclear fractionation |
Scientific reports |
Medium |
26481195
|
| 2017 |
Hsc70 regulates the IRES activity of Enterovirus A71 (EV-A71) and promotes viral replication; Hsc70 knockdown reduces IRES activity and viral RNA/protein levels while overexpression enhances them; Hsc70 binds the viral genomic RNA (not directly the IRES), interacts with 2A protease, and promotes eIF4G cleavage. |
siRNA knockdown, ectopic overexpression, IRES reporter assay, RNA immunoprecipitation, viral replication assay, inhibitor treatment |
Antiviral research |
Medium |
29180285
|
| 2017 |
TDP-43 overexpression in ALS motor neurons post-transcriptionally reduces Hsc70-4/HSPA8 expression by sequestering hsc70-4 mRNA and impairing its translation; reduced HSPA8 impairs the CSP/Hsc70 chaperone complex and dynamin function, causing synaptic vesicle endocytosis defects that can be partially rescued by overexpression of Hsc70-4, CSP, or dynamin. |
Drosophila ALS model, electrophysiology, imaging, genetic interaction (overexpression rescue), mRNA sequestration assay, mouse NMJ analysis, human iPSC neurons |
Cell reports |
High |
28978466
|
| 2018 |
Hsc70 interacts with Alzheimer's tau peptides at the canonical substrate-binding cleft (NMR); the BETA construct (SBD lacking lid) binds the tau sequence GKVQIINKKG with KD ~500 nM under aggregation-promoting conditions and undergoes dramatic rigidification upon substrate binding, similar to DnaK binding geometry but with isoform-specific affinity differences. |
NMR spectroscopy (NOE distance measurements), fluorescent competition assay, allostery assay |
The Journal of biological chemistry |
High |
29764935
|
| 2018 |
HspB1 and Hsc70 inhibit tau fibril formation by distinct mechanisms: Hsc70 is highly efficient at preventing fibril elongation (likely by capping fibril ends) and binds tau significantly tighter under aggregation-promoting conditions, whereas HspB1 weakly delays early aggregation steps; both recognize aggregation-prone motifs in tau's microtubule-binding repeat region. |
Fluorescence spectroscopy, NMR spectroscopy, in vitro fibril formation assay, kinetic analysis |
The Journal of biological chemistry |
High |
29298892
|
| 2018 |
FUNDC1 (mitochondrial outer membrane protein) interacts with HSC70 to promote translocation of unfolded cytosolic proteins to mitochondria for degradation by LONP1 or formation of mitochondria-associated protein aggregates (MAPAs) upon proteasome inhibition; excessive accumulation impairs mitochondrial integrity, activates AMPK, and induces cellular senescence. |
Co-immunoprecipitation, csCLEM, Apex proximity labeling, biochemical fractionation, AMPK signaling analysis |
The EMBO journal |
High |
30591555
|
| 2018 |
Nitric oxide S-nitrosylates Hsc70/HSPA8 within its nucleotide-binding site in neuronal cells constitutively expressing nNOS; this SNO modification impairs Hsc70 function in CMA (shown by LAMP2a loss and accumulation of CMA substrates), leading to protein homeostasis defects and a senescence-like phenotype. |
Redox proteomics, SNO-site identification by MS, full proteome analysis, CMA assay, ubiquitination assay, cell cycle analysis |
Redox biology |
Medium |
30368041
|
| 2018 |
Blocking nuclear export of HSPA8 after heat shock (using P140 phosphopeptide that binds HSPA8 near its nuclear import/export signals) prevents cytoplasmic re-localization of HSPA8 during the recovery phase and severely impairs cell survival when a second oxidative stress is applied, demonstrating that the nuclear-cytoplasmic shuttling of HSPA8 is required for cytoprotection against ROS. |
Stress treatment, P140 peptide tool compound, crosslinking proteomics, fluorescence microscopy, cell viability assay |
Scientific reports |
Medium |
30429537
|
| 2018 |
Apg2 (human Hsp110) shows biphasic regulation of Hsc70 (HspA8): at low concentration it stimulates Hsc70 ATPase activity, aggregate binding, and refolding; at high concentration it inhibits all three. The acidic subdomain of Apg2 acts as a conformational switch that prevents premature ATP dissociation and controls complex dissociation from Hsc70(ATP). |
ATPase assay, aggregate binding assay, refolding assay, deletion mutant analysis, affinity measurements |
Journal of molecular biology |
High |
30521813
|
| 2019 |
LAMP2A directly interacts with Hsc70 at the cytoplasmic surface of lysosomes (photo-crosslinking); its two-domain lumenal architecture regulates this interaction such that the membrane-distal domain is required for full Hsc70 co-immunoprecipitation. |
Site-specific photo-crosslinking in living cells, co-immunoprecipitation, domain truncation constructs |
Experimental cell research |
High |
34942188
|
| 2019 |
NLRC4 forms a complex with HSC70 which negatively regulates caspase-1 activation; the autoinflammatory NLRC4-H443P mutant shows enhanced HSC70 interaction via its NBD and LRR domains (not CARD); cold-induced reduction of NLRC4-H443P–HSC70 interaction leads to increased ASC-speck formation and caspase-1 activation, establishing HSC70 as a temperature-sensitive brake on NLRC4 inflammasome activity. |
Co-immunoprecipitation, siRNA knockdown, ASC-speck formation assay, caspase-1 activation assay, temperature manipulation |
PNAS |
High |
31597739
|
| 2019 |
Mettl21c trimethylates Hspa8 at Lys-561 in type I myofibers, enhancing Hspa8 protein stability; Mettl21c knockout reduces Hspa8 trimethylation and protein levels in slow muscle, and Mettl21c overexpression increases them; Mettl21c-stabilized Hspa8 promotes CMA-dependent degradation of client transcription factors Mef2A and Mef2D. |
Mettl21c knockin/knockout mouse model, co-immunoprecipitation/MS, in vitro methylation assay, Western blot, CMA assay |
The Journal of biological chemistry |
High |
31346037
|
| 2020 |
HSC70 and HSP70 have largely nonoverlapping client specificities despite high sequence similarity; both preferentially associate with newly synthesized polypeptides; expression of a misfolded ALS-linked SOD1 mutant induces global changes in HSC70/HSP70 client association toward disordered polypeptides, revealing network-wide chaperone remodeling. |
UBAIT proximity-tagging fusion strategy, quantitative mass spectrometry, chaperone client identification under normal and stress conditions |
PLoS biology |
High |
32687490
|
| 2020 |
Hsc70 binds to phosphoglycerate kinase (PGK) in living human cells in a cooperative manner that directly correlates with protein thermal unfolding (an 'unfolded-state holding' mechanism), in contrast to Hsp70 which binds before full unfolding; this mechanistic difference correlates with Hsc70's constitutive expression and its multiple cellular functions beyond heat shock. |
In-cell fluorescence binding assay, thermal unfolding correlation, comparison with Hsp70 isoform |
The journal of physical chemistry. B |
Medium |
32275442
|
| 2021 |
LAMP2A directly interacts with Hsc70 at the cytoplasmic surface, and this interaction requires the intact two-domain lumenal architecture of LAMP2A; truncation of the membrane-distal lumenal domain reduces Hsc70 co-immunoprecipitation, revealing intramolecular structural regulation of the Hsc70–LAMP2A CMA docking interaction. |
Site-specific photo-crosslinking in living cells, co-immunoprecipitation, domain truncation |
Experimental cell research |
High |
34942188
|
| 2022 |
Oxidized PRL2 is a substrate selectively recognized by HSC70 under oxidative stress; HSC70 mediates degradation of PRL2 via endosomal microautophagy and CMA, promoting osteoclastogenesis; inhibition of autophagy (hydroxychloroquine) blocks inflammation-induced PRL2 degradation and bone destruction in vivo. |
In vivo mouse models (PRL2 KO, arthritis), co-immunoprecipitation, CMA/eMI assay, hydroxychloroquine rescue |
Cell death and differentiation |
Medium |
36182990
|
| 2023 |
HSPA8 acts as an 'amyloidase' that disassembles RHIM-domain functional amyloids to inhibit necroptosis; the SBD domain of HSPA8 binds RHIM-containing proteins (RIP1, ZBP1, TRIF, RIP3) through a hydrophobic hexapeptide N(X1)φ(X3) motif, preventing amyloid fiber formation; the NBD domain supplies ATP hydrolysis energy to break pre-formed RHIM-amyloids into non-functional monomers, independently of co-chaperones. |
In vitro amyloid formation/disassembly assay, domain mutagenesis, cell-based necroptosis assay, mouse necroptosis model |
Cell research |
High |
37580406
|
| 2023 |
HSPA8 directly interacts with the KIFSN motif on caveolin-1 (CAV1) and promotes CMA-dependent degradation of CAV1; this interaction is enhanced by p38 MAPK-mediated CAV1 S168 phosphorylation; CAV1 degradation releases β-catenin to the nucleus, activating Wnt/β-catenin signaling and driving BRAF V600E colorectal cancer progression. |
Co-immunoprecipitation, CMA assay, p38 MAPK inhibition, β-catenin nuclear translocation assay, in vivo CRC mouse model, VER155008 inhibitor |
Advanced science |
Medium |
37973552
|
| 2023 |
PRMT9 methylates HSPA8 at arginine residues R76 and R100; this arginine methylation stabilizes HSPA8 and suppresses ferroptosis in HBV-associated HCC by upregulating CD44 expression; HBx promotes PRMT9 expression to create an HBx/PRMT9/HSPA8/CD44 anti-ferroptosis axis. |
Co-immunoprecipitation, site-directed mutagenesis, in vitro methylation, transcriptome profiling, in vivo tumor model |
Journal of translational medicine |
Medium |
37715221
|
| 2023 |
HSPA8 enhances HBV replication by recruiting hepatitis B core protein (HBc) to the cccDNA minichromosome; HSPA8 also suppresses ferroptosis by upregulating SLC7A11/GPX4 and decreasing ROS and Fe2+ accumulation; HBx coactivates HSF1 to upregulate HSPA8, forming a positive feedback loop for viral replication. |
ChIP assay (HSPA8 on cccDNA), co-immunoprecipitation, siRNA knockdown, ROS/Fe2+ measurement, in vivo xenograft |
Cancer research |
Medium |
36745032
|
| 2023 |
HSC70 (TGEV M protein SBD interaction): HSC70 binds the coronavirus TGEV membrane protein via its substrate-binding domain; this interaction localizes HSC70 and M protein to the cell surface early in infection and mediates viral internalization through clathrin-mediated endocytosis; HSC70 ATPase activity is required for efficient CME. |
Co-immunoprecipitation, co-localization, anti-M antibody blocking of HSC70 interaction, dynasore/CME inhibitor experiments, ATPase inhibitor |
Journal of virology |
Medium |
36975782
|
| 2024 |
Hsc70 promotes PD-L1 degradation through the endosome-lysosome pathway by binding PD-L1 and blocking the CMTM6–PD-L1 interaction that normally promotes PD-L1 recycling; either Hsc70 overexpression or AUY-922-induced Hsc70 upregulation reduces PD-L1 surface levels, inhibits tumor growth, and enhances anti-tumor immunity in vivo. |
Co-immunoprecipitation (Hsc70–PD-L1; competitive displacement of CMTM6), flow cytometry for PD-L1 levels, in vivo tumor mouse model, Hsc70 overexpression and pharmacologic induction |
Nature communications |
High |
38762492
|
| 2023 |
HSPA8 uses its NBD and LID domains to bind RHOB (residues 1–42 and 89–118) and BECN1's ECD domain; HSPA8 drives liquid-liquid phase separation (LLPS) via intrinsically disordered regions to form droplets that concentrate RHOB and BECN1, enhancing their interaction and protein stability, and thereby promoting anti-bacterial autophagy. |
Co-immunoprecipitation, domain mapping, LLPS assay (droplet formation), intracellular bacteria clearance assay, BECN1/RHOB degradation assay |
Autophagy |
Medium |
37312409
|
| 2015 |
CHIP ubiquitinates Hsc70 itself at multiple lysine residues (16 of 45 detectable), with K159 ubiquitinated in Hsc70 but not Hsp70; multiple Ub chain types are formed with different E2 enzymes; Ube2W preferentially modifies the N-terminal amine of Hsc70; these differences explain why CHIP promotes Hsp70 degradation more efficiently than Hsc70. |
In vitro ubiquitination assay, mass spectrometry-based proteomics, K-R ubiquitin mutants, E2 enzyme comparison |
PloS one |
High |
26010904
|